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Abstract
Purpose To highlight meningoencephalitis as a transient
ischaemic attack (TIA) mimic and suggest clinical clues for
differential diagnosis.
Methods This was an observational study of consecu-
tively admitted patients over a 9.75-year period presenting
as TIAs at a stroke unit.
Results A total of 790 patients with TIAs and seven with
TIA-like symptoms but a final diagnosis of viral menin-
goencephalitis were recognised. The most frequent pre-
sentations of meningoencephalitis patients were acute
sensory hemisyndrome (6) and cognitive deficits (5). Signs
of meningeal irritation were minor or absent on presenta-
tion. Predominantly lymphocytic pleocytosis, hyperprotei-
norachia and a normal cerebrospinal fluid (CSF)/serum
glucose index (in 5 out of 6 documented patients) were
present. Meningeal thickening on a brain magnetic reso-
nance imaging (MRI) scan was the only abnormal imaging
finding. Six patients received initial vascular treatment; one
thrombolysed. Finally, six patients were treated with an-
tivirals and/or antibiotics. Although neither bacterial nor
viral agents were identified on extensive testing, viral
meningoencephalitis was the best explanation for all clin-
ical and laboratory findings.
Conclusions Aseptic meningoencephalitis should be part
of the differential diagnosis in patients presenting as TIA.
The threshold for a lumbar puncture in such patients should
be set individually and take into account the presence of
mild meningeal symptoms, age and other risk factors for
vascular disease, the results of brain imaging and the basic
diagnostic work-up for a stroke source.
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Introduction
Stroke and transient ischaemic attack (TIA) mimics com-
prise a heterogeneous group of non-vascular conditions,
including seizures, migraine with aura, brain tumours,
hypertensive, toxic, metabolic and infectious encephalop-
athies [1–3]. In clinical practice, the initial distinction of
stroke and TIA from their mimics is based on epidemio-
logical and clinical clues, which guide further diagnostic
testing in the acute setting [4].
Infectious meningoencephalitis is a disease caused by
different bacterial or viral agents and with a wide spectrum
of clinical presentations [5–11]. There is a scarcity of data
regarding meningoencephalitis presenting initially as a
cerebrovascular mimic. Hereafter, we describe a consecu-
tive case series of such patients admitted to the stroke unit
of a tertiary care hospital over a 9.75-year period who were
eventually diagnosed as meningoencephalitis and success-
fully treated as such.
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Materials and methods
Design and study population
All patients above the age of 16 years with an initial sus-
picion of TIA, between April 2002 and December 2011, who
were hospitalised in the Stroke Unit of the Centre Hospitalier
Universitaire Vaudois (CHUV, Lausanne, Switzerland) and
whose discharge diagnosis was either TIA or meningoen-
cephalitis, were registered by one of the authors (P.M.).
Details of the medical records were then extracted retro-
spectively from the electronic medical records for the patients
with central nervous system (CNS) infection.
The historical TIA definition of rapidly developed
clinical signs of a focal neurological disturbance of pre-
sumed arterial origin lasting \24 h was used for both
groups of patients [12], independently of whether an acute
ischaemic lesion was present on imaging or not. Menin-
goencephalitis was defined as an acute infection within the
sub-arachnoid space, as indicated by cerebrospinal fluid
(CSF) pleocytosis with white blood cell count (WBC)[5/lL,
also involving the brain parenchyma, as connoted by the
presence of associated neurological symptoms or findings.
Patients with meningoencephalitis accompanied by imag-
ing-confirmed stroke were excluded.
According to the legislation of Canton de Vaud, no
ethical approval is required for this type of study. The
president of the ethics commission for research on humans
of the Canton and the institution’s medical director have
waived the medical secret for all co-authors for this study.
Investigations
All patients were investigated with at least one magnetic
resonance imaging (MRI) scan, including diffusion-
weighted imaging (DWI), and most also had initial
non-contrast head computed tomography (NCCT), CT
angiography (CTA) and CT perfusion (CTP). All patients
underwent at least one arterial study of the neck and brain
arteries [Doppler, MR angiography (MRA) or CTA]. Fur-
ther work-up for potential causes of TIA was performed in
a standardised fashion, as described in a previous report
[13], and included continuous monitoring of vital and
neurological signs, and partially individualised haemato-
logical and cardiac tests. Lumbar puncture (LP) was per-
formed upon the treating neurologist’s recommendation
when (even minor) meningeal symptoms were present,
when work-up for stroke showed neither a source nor an
atherosclerotic lesion or when DWI was normal. CSF was
analysed for the CSF/serum glucose ratio, proteins, cell
count and white cell distribution. Further work-up to
identify a causative agent included: (1) serologic testing for
herpes simplex virus, varicella zoster virus, Epstein–Barr
virus, cytomegalovirus, Borrelia burgdorferi, Brucella
melitensis, Toxoplasma and Treponema, (2) CSF bacterial
cultures and (3) CSF polymerase chain reaction (PCR)
for herpes simplex virus, varicella zoster virus, Borrelia
burgdorferi, mycobacteriums and bacterial DNA. Electro-
encephalogram (EEG) was performed in case of suspicion
of epileptic seizures or confusional state.
Results
Frequency and demographics
During the 9.75-year observation period, 790 patients with
a discharge diagnosis of a TIA (age 71 years, interquartile
range 59–80 years) were hospitalised in our stroke unit. In
27 of these patients (age 52 years, interquartile range
41–60 years, 13 males), the diagnostic work-up included
an LP. In the same period, five Caucasian males and two
females with a median age of 45 years (range 22–75 years)
presented with meningoencephalitis imitating TIA (0.16 %
of all ischaemic strokes and TIAs). We excluded three
patients with stroke due to meningovascular neuroborreli-
osis [14], neurovascular syphilis and toxoplasmosis
abscess, respectively.
Clinical presentation
All patients had sudden onset of focal neurological symp-
toms, except for patient no. 7, whose facio-brachial hyp-
oaesthesia developed over 5 min. The duration of
symptoms ranged from 45 min to 17 h and 30 min (median
510 min), and the delay between focal neurological
symptoms onset and first hospital arrival ranged from 1.6 to
18.0 h (median 9.0 h). These durations of symptoms and
delays to hospital arrival include nighttime sleep duration
in three patients with symptom presentation on awakening.
The most common initial symptom or deficit was a
sensory hemisyndrome in six patients. Mild hemiparesis
was present in two patients and hand weakness in one.
Cognitive function was impaired in the form of confusion
in two patients and aphasia in three; sleepiness was also
present in one of the latter (patient no. 1). Three patients
(nos. 1, 2 and 7) had two TIA-like episodes, which were
separated by 8 days, 8 days, and 5 h, respectively. There
were no initial seizures, but patient no. 4 developed gen-
eralised myoclonia on day 2 and patient no. 6 a partial
status epilepticus on day 4.
Meningeal signs were generally absent or minor. No
patient had fever on arrival and five never developed fever.
Patient no. 4 developed a fever of 38.0 C, 3 h after
admission, attributed to and treated as urinary tract infec-
tion; LP was performed 72 h later when she developed
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status epilepticus. Elevated body temperature in patient no.
6, at about 24 h after admission, was initially attributed to
radiologically and microbiologically confirmed pneumonia
(Streptococcus pneumoniae and Haemophilus influenzae in
bronchoalveolar lavage specimen). LP was performed
within 48 h because of worsening agitation and generalised
myoclonias. There was mild to moderate headache in three
patients, which started before the focal neurological
symptoms in all cases. One patient complained of nausea
and vomiting. Other meningeal symptoms and signs were
absent (see Table 1).
Laboratory findings
The laboratory work-ups are described in Table 1 and were
largely normal. CSF analysis was performed a median of
48 h after admission (range 6–96 h). CSF pleocytosis was
mild to moderate (median WBC 105/lL, range 10–190/
Table 1 Patient characteristics reported on first presentation in the emergency department, laboratory testing on admission, CSF findings on first
testing and treatment
Patient no. 1 2 3 4 5 6 7
Age (years) 45 22 58 75 41 36 64
Sex F M M F M M M
Number of vascular risk
factorsa
0 2 2 4 0 0 0
Time from symptom
onset to first hospital
evaluation (h)
17.0 9.0b 1.6 18.0b 10.0b 2.5 3.5
Duration of neurological
symptoms (min)
1,020 510b 45 1,050b 510b 210 195
Acute neurological deficit
Speech and cranial
nerves
Aphasia Normal Aphasia,
alexia,
agraphia
Right central
facial
paralysis
Mild right
central facial
paralysis
Normal Aphasia
Motor deficits Mild paresis of
left hand
No No Right motor
hemisyndrome
Right motor
hemisyndrome
No No
Sensory deficits Hypoaesthesia
of left hand
Left perioral
and hand
paresthesias
No Right sensory
hemisyndrome
Right sensory
hemisyndrome
Right sensory
hemisyndrome
Left sensory
hemisyndrome
Meningeal symptoms and signs at presentation
Temperature (C) 35.6 (on
analgesics)
36.0 36.0 36.0 36.6 35.7 35.8
Headache Yes Yes No No Yes No No
Vomiting/nausea Yes No No No No No No
Rash, photophobia,
neck stiffness,
Kernig’s and
Brudzinski’s signs
No No No No No No No
Blood tests
WBCs (9109/L) 10.4 6.4 7.5 6.6 6.7 5.8 10.7
CRP (mg/L) 57 \2 \2 20 \2 \2 \2
Glucose (mmol/L) 5.1 5.9 5.2 9.1 7.5 6.4 8.1
Na? (mmol/L) 136 138 137 143 141 142 141
CSF examination
WBCs (/lL) 75 152 126 97 105 10 190
Polymorphonuclear
(%)
1.5 1.5 4 85 0.3 1.5 3.5
Lymphocytes (%) 90 94.5 92 15 94.5 90.5 95
RBCs (/lL) 0 2 20 4 28 387 1
Protein (g/L) 0.500 0.821 0.570 0.924 1.373 1.157 1.355
Glucose (mmol/L) 2.8 3.3 3.4 7.4 3.5 4.6 3.8
Treatment
Initial cardiovascular
treatment
Aspirin
300 mg
None Aspirin
300 mg
Aspirin 300 mg None Intravenous
thrombolysis
Aspirin 100 mg
Antimicrobial/antiviral
treatment
Both Antiviral Not
documented
Both Antiviral Both Both
WBC white blood cell, CRP C-reactive protein, CSF cerebrospinal fluid, RBC red blood cell
a Major vascular risk factors considered (other than age and sex): previous stroke/TIA, family history of stroke, current smoking, alcohol consumption,
atrial fibrillation, hypertension, hypercholesterolaemia and diabetes mellitus
b Including nighttime sleep in patients with neurological symptoms present on awakening
Meningoencephalitis as TIA mimic 487
123
lL), but clearly higher than we usually observe in stroke
patients [4]. Lymphocytic predominance [90 % was evi-
dent in six patients and polymorphonuclear (85 %) in one.
CSF protein concentration was elevated in all patients
(median value 0.924 g/L, range 0.500–1.373 g/L). Five out
of six patients in whom it was documented had a normal
CSF/serum glucose index and one had an absolute decrease
of glucose CSF levels (2.8 mmol/L). Further work-up to
identify a causative agent was negative in all patients in
both serum and CSF.
In the TIA group patients that were investigated with an
LP, the examination was performed a median of 4.2 days
after admission (interquartile range 2.0–6.5 days). CSF
WBC was normal (median WBC 1/lL, interquartile range
0.5–1/lL), except for one patient who had borderline CSF
pleocytosis (WBC 6/lL), which we attributed to an
imaging-proven cerebellar stroke 10 days earlier. CSF
protein concentration was within the normal range (median
value 0.428 g/L, interquartile range 0.345–0.516 g/L) in
most patients.
Imaging findings
Six patients were initially investigated with NCCT and
CTA and five also had an acute CTP. In patient no. 6, the
CTP had movement artifacts and showed a possible pro-
longation of the mean transit time in the left hemisphere.
On CTA, MRA and Doppler, three patients showed some
atherosclerosis, with patient no. 7 being the only one with a
[50 % stenosis, located at the origin of the right vertebral
artery and, therefore, not explaining his aphasia and left
sensory hemisyndrome. One female patient had brain MRI
as the initial imaging and the others during hospitalisation.
All MRIs were normal, except in patient no. 4, where
meningeal thickening compatible with acute meningitis
was revealed; in particular, no parenchymal findings sug-
gestive of encephalitis was found, which is the most fre-
quent situation in viral meningoencephalitis other than
herpes virus [15]. No signs of cortical vein thrombosis
were detected on T1, T2 and fluid-attenuated inversion
recovery (FLAIR) images. An EEG was performed in six
patients, with abnormal findings (generalised triphasic non-
periodical elements) only recorded in patient no. 4 with
status epilepticus.
Treatment and clinical outcome
Five patients initially received cardiovascular drugs,
including patient no. 6 with acute-onset right sensory
hemisyndrome and confusional state (considered as fluent
aphasia), who was erroneously thrombolysed with intra-
venous rtPA at 210 min. The patient’s hemisyndrome
cleared quickly, but the subject then developed agitation
requiring sedation and intubation, and pneumonia the next
day. Aetiological work-up for stroke and meningoenceph-
alitis was negative in all seven patients.
Antivirals and/or antibiotics were initially given for the
meningoencephalitis in all six patients, where documented.
All patients were discharged home after a median of
11 days (range 5–29 days) with complete remission of
symptoms and no recurrent cerebral symptoms over the
ensuing 3 months.
Discussion
We described seven consecutive adults presenting to a
single stroke unit over a 9.75-year period with an acute,
transient focal neurological deficit which imitated TIA but
were finally diagnosed as viral meningoencephalitides.
These patients were younger, had few cerebrovascular risk
factors, often pure sensory symptoms and longer than usual
duration of TIA. Meningeal symptoms, if present, were
either minor or appeared later in the course. Of note, none
had fever or meningism on admission. Brain and arterial
work-up for causes of stroke was negative.
There are only sporadic case reports of meningitis as
stroke mimic mainly associated with the presence of
interesting (mostly bacterial) isolates in the culture results
[16–25]. Data from meta-analyses also identify a low
incidence of meningitis among stroke mimics [1, 2, 26–31].
Compared to other mimics that may be easier to diagnose,
such as seizures (witness history), hypoglycaemia (acute
glycaemia measures), migraine with aura (history of pro-
gressive onset, focal headaches), peripheral vestibular
dysfunction (positive head thrust or caloric middle ear
testing) and systemic infection (fever, CRP, WBC),
meningoencephalitis may be more difficult to suspect and
exclude.
In our population, the arguments to search for an alter-
native diagnosis were several: first, the patients were rather
young and had few stroke risk factors, apart from one
elderly patient with diabetes and hypertension (patient no.
4). Secondly, transient pure or predominant hemisensory
symptoms were frequent. Thirdly, the duration of symp-
toms was rather long, with a median of 510 min, whereas
TIAs typically last 10–180 min [3]. Fourth, there were
sometimes minor meningeal symptoms and signs which are
rare in strokes and TIAs: (mild) headache, confusional
state, nausea or vomiting; in some patients, such symp-
toms, including fever and epileptic seizures, appeared
during hospitalisation. Fifth, all patients had negative brain
imaging, and, lastly, work-up for stroke did not reveal
significant embolic sources.
In one of our patients, an erroneous thrombolysis deci-
sion was made partially based on the over-interpretation of
488 V. Papavasileiou et al.
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subtle focal abnormalities on a CTP with movement arte-
facts; this intervention remained without serious conse-
quences [31, 32]. Intravenous thrombolysis may be given
occasionally for stroke mimics [31, 32]; this is not only due to
atypical clinical presentations that may not be recognised, but
also to the little time available for emergency room physi-
cians and neurologists before taking treatment decisions
[33, 34]. Furthermore, the poor sensitivity of NCCT as
compared to CTP and, in particular, DWI MRI [35] can
partially explain why there is no golden standard for skipping
the stroke-mimic trap.
Limitations of our study include the fact that we were
unable to confirm the presence of a viral agent in any of our
patients. This may be due to the sensitivity of CSF PCR,
which varies with different viruses, and can be dramatically
influenced by the timing of specimen collection in relation
to the onset of illness [36]. Other possible explanations of
negative CSF PCRs include unknown infectious agents,
unusual infectious agents not covered in the tests employed
or known agents missed because of false-negative PCRs
[36]. Recent studies on patients with typical presentation of
meningitis or encephalitis lead to 43 and 17 % of a PCR-
proven diagnosis, respectively, questioning whether these
relatively small identified proportions constitute the total
number of infective causes [37].
The fact that the aetiologic agent was not identified in our
patients raises the question as to whether any of them were
misclassified as meningoencephalitides instead of TIAs.
However, previous studies in stroke patients showed that
70–90 % of ischaemic cerebrovascular events are accompa-
nied by normal CSF WBCs [38]. Similarly, in another study
including patients with ischaemic stroke and clear CSF, no
value[10 WBCs/lL was recorded [39]. In the latter study,
CSF protein values were \0.50 g/L in 62 % of measured
cases and only slightly elevated (0.5–1.0 g/L) in 38 %. Recent
studies prove that the elevation of specific protein molecules
in CSF tested, such as S100B, is correlated with stroke severity
and infarct volume, challenging the attribution of elevated
CSF protein to a probable TIA [4]. In TIA patients, milder
CSF abnormalities should also be expected, taking into
account the absence of permanent brain damage compared to
strokes. The CSF results of our TIA patients that were
investigated with an LP match the above-mentioned reports
and support our hypotheses that the CSF abnormalities in our
patients should, most probably, not be attributed to TIAs.
Of note, other causes of non-viral aseptic meningitis
such as drugs (e.g. trimethoprim–sulphamethoxazole or
non-steroidal anti-inflammatory drugs), leptomeningeal
cancer, sarcoidosis or immune-mediated diseases (e.g.
systemic lupus erythematosus or CNS vasculitis) may be
rather safely excluded by patients’ history, clinical exam-
ination, laboratory and imaging studies, and the benign
course of the symptoms.
We cannot exclude that some of our patients with
headache may had a syndrome of transient headache and
neurological deficits with CSF lymphocytosis (HaNDL);
however, the onset of focal symptoms was abrupt in our
patients, headaches were absent or minor, and other epi-
sodes of headache and neurological deficits did not recur
within the first 3 months [40]. Another possible diagnosis
could be viral-meningitis-associated vasculopathy; how-
ever, this seems rather unlikely based on the clinical his-
tory (e.g. absence of previous trigeminal zoster and rash, as
in cases of varicella zoster virus infection) and the negative
radiological findings (CTA and MRI), despite the fact that
small-artery abnormalities cannot always be safely exclu-
ded [41, 42]. Moreover, we may have missed a diagnosis of
meningoencephalitis in some other patients presenting as
TIA because we do not perform LP in all our patients with
a TIA diagnosis.
Rapid and correct diagnosis of TIA and stroke is of
paramount importance, since aggressive work-up and early
prevention of recurrences [43], acute treatment of strokes
[34] and admission to stroke units are highly effective
interventions [44].
In conclusion, meningoencephalitis should be part of the
differential diagnosis in patients with a suspected TIA. The
decision to perform an LP should be made on an individual
basis and consider the presence of mild meningeal symp-
toms, age and other risk factors for vascular disease, the
results of brain imaging and the basic diagnostic work-up
for a stroke source.
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